Skip to content
Search

Latest Stories

Johnson & Johnson is the world’s most innovative pharmaceutical company

Johnson & Johnson is the world’s most innovative pharmaceutical company

Johnson & Johnson spent £37.1 billion on intangible assets and £11.87 billion on R&D last year

Johnson & Johnson has made it to the list of top 10 most innovative companies in the world released by FOREX.com.


The US-based pharmaceutical company is the fourth most innovative company, scoring 8.23/10 in the innovation index.

Johnson & Johnson is the only pharmaceutical company making it to top 10 list, which makes it the world’s most innovative pharmaceutical company in 2023.

The ranking is based on many factors such as the number of US-registered patents in 2022, the number of R&D expenses over the last 12 consecutive months and their last reported intangible assets.

The health giant spent £37.16 billion on intangible assets (the second highest after Apple), £11.87 billion on R&D last year and registered 1,377 patents last year.

Consumer electronic companies dominated the list, securing the top three spots.

Samsung tops the list with an innovation score of 9.25/10 and the highest number of new patents in 2022 (8,513).

Matthew Weller, Head of Global Market Commentary at FOREX.com, said: “The report's findings underscore Samsung's dominance in the innovation arena, with its leading number of patents reflecting a significant push in consumer electronics. This patent portfolio is not just a measure of quantity but a marker of Samsung's potential to disrupt markets and set new industry standards.”

Despite having spent the most on intangible assets out of all companies, Apple slipped to second position in the list, scoring 9.03/10.

IT giant IBM is in the third place with a score of 8.33/10 and the second highest number of new patents registered in 2022 (4743).

Intel invested 31.6 per cent (£13.6 billion) of their £43 billion revenue - the most out of all companies.

E-commerce giant, Amazon, has invested the most in R&D in the last year (£65 billion).

Experts at FOREX.com have prepared the list by analysing data from Harrity and Seeking Alpha to uncover which companies are the most innovative.

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less